Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC · Nasdaq

Fennec Pharmaceuticals Inc. (FENC) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Fennec Pharmaceuticals Inc. in 2026. The next earnings report is expected on November 5, 2026.

Earnings calendar

Next earnings date

05 Nov 2026

In 77 days

EPS estimate

0.09

Revenue estimate

18.5M

Past earnings

11 Aug 2026
EPS actual
0.03 (+25.0%)
estimate 0.02
Revenue actual
16.4M (+0.9%)
estimate 16.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
14 May 2026
EPS actual
0.01 (+122.8%)
estimate -0.04
Revenue actual
15.1M (+8.6%)
estimate 13.9M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
24 Mar 2026
EPS actual
-0.17 (-506.2%)
estimate 0.04
Revenue actual
13.8M (-5.8%)
estimate 14.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
13 Nov 2025
EPS actual
-0.02 (+8.7%)
estimate -0.02
Revenue actual
12.6M (+12.5%)
estimate 11.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Fennec Pharmaceuticals beat consensus estimates in its latest earnings report, with EPS of USD 0.025 versus an estimate of USD 0.02 and revenue of USD 16.36 million, exceeding estimates by 0.9%. In the prior quarter both EPS and revenue also came in ahead of expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Jeffrey S. Hackman
Employees
32
IPO date
15 Sep 2017
ISIN
CA31447P1009
Website
fennecpharma.com

Frequently asked questions

When does Fennec Pharmaceuticals Inc. (FENC) next report earnings?

Fennec Pharmaceuticals Inc. (FENC) is scheduled to report earnings on November 5, 2026.

What was Fennec Pharmaceuticals Inc.'s most recent earnings date?

Fennec Pharmaceuticals Inc. (FENC) last reported earnings on August 11, 2026.

Where is Fennec Pharmaceuticals Inc. stock listed?

Fennec Pharmaceuticals Inc. (FENC) is listed on Nasdaq.